Publié le 07 Décembre 2023
Postdoctoral Position in cell matrix biology & antibody-drug conjugate
Application deadline: 31 January, 2024
Anticipated start date: ASAP 2024
The team (Breast cancer, Microenvironment and Immunotargeting) at Montpellier Cancer Research Institute (France) is looking for a postdoctoral researcher to work on the optimization of antibody-drug conjugates targeting matricellular proteins in breast cancer. This postdoctoral fellowship is part of a priority research program and equipment (PEPR) ACCREDIA, which brings together a lab network of seven academic partners funded by the French government to improve knowledge, skills and methodologies in antibody development. The position is funded in the frame of French PEPR-PIA4 Accredia ANR-22-PEBI-0009 for a period of 2 to 3 years.
More